AU3069192A - Hiv protease inhibitors containing guanidine - Google Patents
Hiv protease inhibitors containing guanidineInfo
- Publication number
- AU3069192A AU3069192A AU30691/92A AU3069192A AU3069192A AU 3069192 A AU3069192 A AU 3069192A AU 30691/92 A AU30691/92 A AU 30691/92A AU 3069192 A AU3069192 A AU 3069192A AU 3069192 A AU3069192 A AU 3069192A
- Authority
- AU
- Australia
- Prior art keywords
- protease inhibitors
- hiv protease
- inhibitors containing
- containing guanidine
- guanidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 title 2
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 title 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 title 1
- 239000004030 hiv protease inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- AIDS & HIV (AREA)
- Biochemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78643591A | 1991-11-01 | 1991-11-01 | |
| US786435 | 1991-11-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU3069192A true AU3069192A (en) | 1993-06-07 |
Family
ID=25138568
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU30691/92A Abandoned AU3069192A (en) | 1991-11-01 | 1992-10-30 | Hiv protease inhibitors containing guanidine |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0610431A1 (en) |
| JP (1) | JPH07501056A (en) |
| AU (1) | AU3069192A (en) |
| MX (1) | MX9206294A (en) |
| PT (1) | PT101026A (en) |
| WO (1) | WO1993009132A1 (en) |
| ZA (1) | ZA928396B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5430150A (en) * | 1992-12-16 | 1995-07-04 | American Cyanamid Company | Retroviral protease inhibitors |
| US5455351A (en) * | 1993-12-13 | 1995-10-03 | Abbott Laboratories | Retroviral protease inhibiting piperazine compounds |
| AUPM623994A0 (en) * | 1994-06-15 | 1994-07-07 | Biomolecular Research Institute Limited | Antiviral dendrimers |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3809145A1 (en) * | 1988-03-18 | 1989-09-28 | Merck Patent Gmbh | AMINOSAEUREDERIVATE |
| DE3812328A1 (en) * | 1988-04-14 | 1989-10-26 | Merck Patent Gmbh | AMINOSAEUREDERIVATE |
| IL91307A0 (en) * | 1988-08-24 | 1990-03-19 | Merck & Co Inc | Hiv protease inhibitors and pharmaceutical compositions for the treatment of aids containing them |
-
1992
- 1992-10-30 WO PCT/US1992/009402 patent/WO1993009132A1/en not_active Ceased
- 1992-10-30 JP JP5508659A patent/JPH07501056A/en active Pending
- 1992-10-30 AU AU30691/92A patent/AU3069192A/en not_active Abandoned
- 1992-10-30 EP EP92924217A patent/EP0610431A1/en not_active Withdrawn
- 1992-10-30 ZA ZA928396A patent/ZA928396B/en unknown
- 1992-10-30 PT PT101026A patent/PT101026A/en not_active Application Discontinuation
- 1992-10-30 MX MX9206294A patent/MX9206294A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX9206294A (en) | 1993-08-01 |
| JPH07501056A (en) | 1995-02-02 |
| EP0610431A1 (en) | 1994-08-17 |
| PT101026A (en) | 1994-05-31 |
| ZA928396B (en) | 1993-05-12 |
| WO1993009132A1 (en) | 1993-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA929869B (en) | Hiv protease inhibitors | |
| AU9122391A (en) | Hiv protease inhibitors | |
| KR100190517B1 (en) | Hiv protease inhibitors | |
| PH31249A (en) | Inhibitors of hiv protease. | |
| AU4091093A (en) | Alpha-alumina | |
| IL110752A0 (en) | Pharmaceutical composition for an hiv protease inhibitor | |
| IL102534A0 (en) | Retroviral protease inhibitors | |
| AU6135294A (en) | Piperazine derivatives as hiv protease inhibitors | |
| AU5069993A (en) | Retroviral protease inhibitors | |
| EP0480714A3 (en) | Hiv protease inhibitors having symmetrical structure | |
| AU7131991A (en) | Hiv protease inhibiting agents | |
| AU3735793A (en) | Retroviral protease inhibitors | |
| AUPM982594A0 (en) | HIV protease inhibitors | |
| AU2151992A (en) | Anti-foaming agents | |
| AU7132091A (en) | Hiv protease inhibitors containing derived amino acid units | |
| AU7132391A (en) | Hiv protease inhibitors | |
| AU7732691A (en) | Hiv protease inhibitors and processes for their preparation | |
| AU6828894A (en) | Hiv protease inhibitors | |
| EP0594586A4 (en) | Hiv protease inhibitors | |
| AU2642492A (en) | Peptide isoters containing a heterocycle as h.i.v. inhibitors | |
| AU3069192A (en) | Hiv protease inhibitors containing guanidine | |
| EP0566237A3 (en) | Retroviral protease inhibitors. | |
| EP0575500A4 (en) | Hiv protease inhibitors | |
| GB9318445D0 (en) | Hiv protease in inhibitor compounds | |
| AU2894192A (en) | Cns active tetrahydrobenzothienopyridines |